Shanghai Fosun Pharmaceutical (Group) unit gets approval for drug clinical trial from FDA
Oct 30 (Reuters) - Shanghai Fosun Pharmaceutical (Group) Co Ltd <600196.SS> ::Says its unit gets approval for drug (FN-1501) clinical trial from FDA.
Latest Developments forShanghai Fosun Pharmaceutical Group Co Ltd
- Shanghai Fosun Pharmaceutical Group unit gets approval for HLX10 clinical trail
- Shanghai Fosun Pharma's unit signs agreement to buy France's Tridem Pharma
- Shanghai Fosun Pharmaceutical Group unit passes FDA approval for new drug clinical trail
- Fosun International comments on proposed spin-off and separate listing of Sisram Medical